original ) (raw )Data from ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
Olle Stål
2023
View PDFchevron_right
Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription
Carolyn Klinge
Molecular and Cellular Endocrinology, 2010
View PDFchevron_right
Estrogen Receptor-α Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast Cancer
Olle Stål
Clinical Cancer Research, 2010
View PDFchevron_right
Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients
Angela Diblasi
The Journal of Steroid Biochemistry and Molecular Biology, 1998
View PDFchevron_right
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers
E. Kisanga
Journal of the …, 2003
View PDFchevron_right
Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial
Kirsten Nielsen
European Journal of Cancer, 2014
View PDFchevron_right
Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women
Garnet Anderson
American Journal of Epidemiology, 2008
View PDFchevron_right
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study
Jean Wactawski-wende
Breast Diseases: A Year Book Quarterly, 2013
View PDFchevron_right
Tamoxifen Induces Heparanase Expression in Estrogen Receptor Positive Breast Cancer
Amichay Meirovitz
Clinical Cancer Research, 2007
View PDFchevron_right
Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study
Yu-Tang Gao
American Journal of Epidemiology, 2011
View PDFchevron_right
Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2 -Negative Breast Cancer Treated With and Without Tamoxifen Therapy
Olle Stål
JAMA network open, 2021
View PDFchevron_right
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Geraldine Laven-Law
Nature Medicine, 2021
View PDFchevron_right
Estrogen Induces Repression of the Breast Cancer and Salivary Gland Expression Gene in an Estrogen Receptor Dependent Manner
Nicola Miller
Cancer Research, 2008
View PDFchevron_right
Physiological and Pathological Roles of Estrogen Receptor
Kenneth Korach
Estrogen Receptor and Breast Cancer, 2018
View PDFchevron_right
Amplified in Breast Cancer 1 in Human Epidermal Growth Factor Receptor-Positive Tumors of Tamoxifen-Treated Breast Cancer Patients
Kirsten Nielsen
Clinical Cancer Research, 2007
View PDFchevron_right
Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor‑positive/progesterone receptor‑negative breast cancer
Olle Stål
Molecular and Clinical Oncology, 2020
View PDFchevron_right
Predicting Risk of Breast Cancer in Postmenopausal Women by Hormone Receptor Status
Garnet Anderson
JNCI Journal of the National Cancer Institute, 2007
View PDFchevron_right
Elucidating the role of androgen receptor in breast cancer
Aditi H
Clinical Investigation, 2012
View PDFchevron_right
Aromatase inhibitors in breast cancer
Manisha Kotadiya , jaydeep savaliya
The American Journal of Geriatric Pharmacotherapy, 2004
View PDFchevron_right
Variation of hormonal receptor, pS2, c-erbB-2 and GSTπ contents in breast carcinomas under tamoxifen: a study of 74 cases
Isabelle Soubeyran
British Journal of Cancer, 1996
View PDFchevron_right
Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma
Graham Colditz
Cancer, 2004
View PDFchevron_right
American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction
David Samson
Gynecologic Oncology, 2009
View PDFchevron_right
BreastDefend Enhances Effect of Tamoxifen in Estrogen Receptor-positive Human Breast Cancer in Vitro and in Vivo
Dr. Isaac Eliaz
2019
View PDFchevron_right
Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model
joseph ragaz
JNCI Journal of the National Cancer Institute, 2004
View PDFchevron_right
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines
Francesca De Amicis
Breast Cancer Research, 2014
View PDFchevron_right
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
Garnet Anderson
Breast Cancer Research, 2018
View PDFchevron_right
Estrogen and progesterone receptor mrna levels in primary breast cancer: Association with patient survival and other clinical and tumor features
Maria Nagai
International Journal of Cancer, 1994
View PDFchevron_right
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer
Susan Hilsenbeck
Breast Cancer Research and Treatment, 2010
View PDFchevron_right
Clinical and molecular aspects of breast cancer: Targets and therapies
Glauber Leitao
Biomedicine & Pharmacotherapy, 2018
View PDFchevron_right
What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
Ricardo Caponero
Annals of Oncology, 2009
View PDFchevron_right
9q31. 2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
E. Khusnutdinova
2012
View PDFchevron_right
Breast Cancer Risk and the Combined Effect of Environmental Estrogens
Nicolas Olea
Cancer Causes & Control, 2004
View PDFchevron_right
Tamoxifen and fenretinide in women with metastatic breast cancer
Maria Merino
Breast Cancer Research and Treatment, 1999
View PDFchevron_right
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer
Bianca Gibelli
Breast Cancer Research and Treatment, 2013
View PDFchevron_right
P21-Activated Kinase 1 Regulation of Estrogen Receptor-α Activation Involves Serine 305 Activation Linked with Serine 118 Phosphorylation
Sohaib Khan
Cancer Research, 2006
View PDFchevron_right